Abstract |
Five different lipid conjugates of 1-beta-D-arabinofuranosylcytosine ( ara-C) were tested for their therapeutic activity on the growth and metastasis of Lewis lung carcinoma (3-LL). Among 1 ester-linked lipid conjugate (Ara- CDP-L- dipalmitin), 3 1-O-alkyl-lipid conjugates (ara- CDP-D,L-PBA, ara- CDP-D,L-PCA, ara- CDP-D,L-MBA) and a thioether- lipid conjugate (ara- CDP-D,L-PTBA) ara- CDP-D,L-PTBA, ara- CDP-D,L-PBA, and ara- CDP-L- dipalmitin produced the strongest tumor growth inhibition and increase of surviving animals in C57Bl6-mice bearing i.p.-implanted 3-LL. Furthermore these conjugates were superior to the parent compounds alone, or equimolar mixtures of the alkyllysophospholipid derivatives ET-18-OCH3 and ara-C. Successful therapeutic regimen consisted of 80-100 mg conjugate/kg, given i.p. daily for five consecutive days. Similar regimen injected shortly after the surgical removal of the primary tumor as adjuvant chemotherapy inhibited the metastasis of 3-LL to the lungs of the animals as demonstrated by an increase of survival time and the number of surviving animals.
|
Authors | W E Berdel, S Danhauser, C I Hong, H D Schick, A Reichert, R Busch, J Rastetter, W R Vogler |
Journal | Cancer research
(Cancer Res)
Vol. 48
Issue 4
Pg. 826-9
(Feb 15 1988)
ISSN: 0008-5472 [Print] United States |
PMID | 3338080
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
|
Topics |
- Animals
- Cytarabine
(analogs & derivatives, therapeutic use)
- Esters
- Female
- Lipids
(therapeutic use)
- Lung Neoplasms
(drug therapy, pathology, secondary)
- Mice
- Mice, Inbred C57BL
- Neoplasm Metastasis
- Structure-Activity Relationship
|